Direkt zum Inhalt

Kaltenböck, A. ; Dubischar-Kastner, K. ; Eder, G. ; Jilg, W. ; Klade, C. ; Kollaritsch, H. ; Paulke-Korinek, M. ; von Sonnenburg, F. ; Spruth, M. ; Tauber, E. ; Wiedermann, U. ; Schuller, E.

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

Kaltenböck, A., Dubischar-Kastner, K., Eder, G., Jilg, W., Klade, C., Kollaritsch, H. , Paulke-Korinek, M., von Sonnenburg, F., Spruth, M., Tauber, E. , Wiedermann, U. and Schuller, E. (2009) Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study. Vaccine 27 (33), pp. 4483-4489.

Date of publication of this fulltext: 19 Dec 2024 12:04
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleVaccine
Publisher:ELSEVIER SCI LTD
Place of Publication:OXFORD
Volume:27
Number of Issue or Book Chapter:33
Page Range:pp. 4483-4489
Date2009
InstitutionsMedicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Identification Number
ValueType
10.1016/j.vaccine.2009.05.034DOI
KeywordsANTIBODY; POPULATION; Concomitant vaccination; IC51; Japanese encephalitis; Travel; Hepatitis A; Interaction
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID67036

Export bibliographical data

Owner only: item control page

nach oben